Investing.com - Scpharmaceuticals reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Scpharmaceuticals announced earnings per share of $-0.370 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.400 on revenue of $0.00.
Scpharmaceuticals shares are up 86.39% from the beginning of the year , still down 20.88% from its 52 week high of $6.80 set on Monday, October 3, 2022.
Scpharmaceuticals follows other major Healthcare sector earnings this month
Scpharmaceuticals's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar